The first Alzheimer’s blood test, which was erased by the Food and Drug Administration, can make the diagnosis more access and accurately and change the way the doctor treats the disease.
Westend61/Getty Image
Hide the caption
Caption toggle
Westend61/Getty Image
A new blood test that detects the characteristics of Alzheimer’s is ready to change the way a doctor diagnoses and treats the disease.
This is the first test Deletion It is for people over 55 years of age who have already had a memory problem or signs and symptoms of other Alzheimer’s.
The result shows whether there is a lump of toxic protein that accumulates in the space between amyloid plaque and brain cells in the brain of a person with cognitive symptoms. The presence of a plaque of a person with cognitive symptoms usually checks Alzheimer’s diagnosis.
“I think blood tests will actually revolutionize the way Alzheimer’s people are cared for and diagnoses.” Dr. Howard Phil RetThe chief science officer of the Alzheimer’s Discovery Foundation.
“The primary doctor will now be able to access something that can read faster whether the patient has Alzheimer. Maria KariloThe chief scientific officer of the Alzheimer’s Association.
One of the advantages of blood tests that can be easily obtained would be more accurate diagnosis, Fillit pointed out that the primary doctor currently diagnoses only about 60% of the patient.
“Professional neurologists get right like 70, 80 %,” he says. “Blood tests allow you to get up to 90%or more.”
no way Pet scan It is a gold standard for detecting amyloid plaque related to Alzheimer’s. However, this technology is expensive in many communities and cannot be used.
Another option is to test the fluid in the spinal tab, which is an invasive procedure that tends to avoid most doctors and patients.
There is already a blood test that has developed a laboratory to know the existence of amyloid. However, the Lumipulse analysis created by the diagnostic firm Fujirebio is the first to receive marketing permits from the FDA.
If you have such a test, more people will be diagnosed when the symptoms can still be mild and potentially treated.
According to a survey by the Alzheimer ‘S Association, most elderly people will have a blood test to find out if they have a disease.
Those who have been diagnosed while Alzheimer’s early stages may deserve one of the two amyloid reduction drugs on the market.
Blood tests developed by the laboratory were mainly used by experts in researchers or large medical centers. FDA’s tests will attract a much broader audience.
Carrillo said, “This is a strict assessment and provides guidance for prescribers who are qualified and who should be tested.
The result is to test more people in rural or marginalized areas.
Carrillo said, “Blood test has given us the opportunity to actually democratize this kind of test.
It also means that there are more estimates 7.2 million Americans It is likely to be officially diagnosed by being thought to be living with Alzheimer.
In order to help the provider of health and health services to advise these individuals, the Alzheimer’s Association is preparing a guideline to the patient on what it means to live with the disease and what treatment options are.
This guideline is expected this summer.
